Donovan JL - Search Results

1

Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT.

Hamdy FC, Elliott D, le Conte S, Davies LC, Burns RM, Thomson C, Gray R, Wolstenholme J, Donovan JL, Fitzpatrick R, Verrill C, Gleeson F, Singh S, Rosario D, Catto JW, Brewster S, Dudderidge T, Hindley R, Emara A, Sooriakumaran P, Ahmed HU, Leslie TA. Hamdy FC, et al. Among authors: donovan jl. Health Technol Assess. 2018 Sep;22(52):1-96. doi: 10.3310/hta22520. Health Technol Assess. 2018. PMID: 30264692 Free PMC article. Clinical Trial.

2

Dilemmas in treating early prostate cancer: the evidence and a questionnaire survey of consultant urologists in the United Kingdom.

Donovan JL, Frankel SJ, Faulkner A, Selley S, Gillatt D, Hamdy FC. Donovan JL, et al. BMJ. 1999 Jan 30;318(7179):299-300. doi: 10.1136/bmj.318.7179.299. BMJ. 1999. PMID: 9924055 Free PMC article. No abstract available.

3

Unanswered questions in screening for prostate cancer.

Neal DE, Leung HY, Powell PH, Hamdy FC, Donovan JL. Neal DE, et al. Among authors: donovan jl. Eur J Cancer. 2000 Jun;36(10):1316-21. doi: 10.1016/s0959-8049(00)00104-0. Eur J Cancer. 2000. PMID: 10882874 Review.

4

Screening for prostate cancer in the UK. Seems to be creeping in by the back door.

Donovan JL, Frankel SJ, Neal DE, Hamdy FC. Donovan JL, et al. BMJ. 2001 Oct 6;323(7316):763-4. doi: 10.1136/bmj.323.7316.763. BMJ. 2001. PMID: 11588064 Free PMC article. No abstract available.

5

Recent trends in the use of radical prostatectomy in England: the epidemiology of diffusion.

Oliver SE, Donovan JL, Peters TJ, Frankel S, Hamdy FC, Neal DE. Oliver SE, et al. Among authors: donovan jl. BJU Int. 2003 Mar;91(4):331-6; discussion 336. doi: 10.1046/j.1464-410x.2003.04083.x. BJU Int. 2003. PMID: 12603408

6

Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study.

Mills N, Donovan JL, Smith M, Jacoby A, Neal DE, Hamdy FC. Mills N, et al. Among authors: donovan jl. Control Clin Trials. 2003 Jun;24(3):272-82. doi: 10.1016/s0197-2456(03)00020-5. Control Clin Trials. 2003. PMID: 12757993 Clinical Trial.

7

Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.

Hamdy FC, Donovan JL, Lane JA, Neal DE. Hamdy FC, et al. Among authors: donovan jl. BMJ. 2003 Jun 28;326(7404):1456. doi: 10.1136/bmj.326.7404.1456. BMJ. 2003. PMID: 12829565 Free PMC article. No abstract available.

8

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).

Donovan JL, Peters TJ, Noble S, Powell P, Gillatt D, Oliver SE, Lane JA, Neal DE, Hamdy FC; ProtecT Study Group. Donovan JL, et al. J Clin Epidemiol. 2003 Jul;56(7):605-9. doi: 10.1016/s0895-4356(03)00083-0. J Clin Epidemiol. 2003. PMID: 12921927 Clinical Trial.

9

Gunnell D, Oliver SE, Donovan JL, Peters TJ, Gillatt D, Persad R, Hamdy FC, Neal DE, Holly JM. Gunnell D, et al. Among authors: donovan jl. J Clin Endocrinol Metab. 2004 Jan;89(1):213-8. doi: 10.1210/jc.2003-030507. J Clin Endocrinol Metab. 2004. PMID: 14715852

10

Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer.

Oliver SE, Barrass B, Gunnell DJ, Donovan JL, Peters TJ, Persad RA, Gillatt D, Neal DE, Hamdy FC, Holly JM. Oliver SE, et al. Among authors: donovan jl. Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):163-5. doi: 10.1158/1055-9965.epi-03-0102. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 14744750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

474 results

Search Page